Ultrasound Characteristics of Keratoacanthoma DOI Open Access

Yan‐xuan Chen,

Jian‐Feng Liang, Xiao Li

и другие.

Journal of Ultrasound in Medicine, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 20, 2024

This study aims to describe the ultrasound characteristics of keratoacanthoma (KA), providing valuable insights for non-invasive diagnosis and differentiation from well-differentiated cutaneous squamous cell carcinoma (wcSCC). Ultrasound 16 KA 13 wcSCC conformed by surgical pathology were retrospective analyzed. patients younger (mean age 63.13 years) compared with 76.23 years). revealed that lesions generally smaller, more frequently domed-shaped (87.50 vs 38.46%), exophytic (93.75 30.77%), well-defined 53.85%) wcSCC. Both lesion types predominantly showed hypoechoic internal echoes inhomogeneous echotexture. The prevalence hyperechoic superficial area was notably high in both groups 84.62%), precluding reliable use this feature as a discriminatory marker between these two distinct neoplastic entities. mostly confined epidermis dermis (87.50%), while cases infiltrated into subcutaneous fat layer (84.62%). Color Doppler imaging demonstrated higher vascularity lesions, 61.5% showing Grade 3 flow, where 62.5% exhibited 2 flow. High-frequency reveals differentiating wcSCC, offering promising tool preliminary treatment planning.

Язык: Английский

Pathophysiology, Histopathology, and Differential Diagnostics of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma—An Update from the Pathologist’s Point of View DOI Open Access
Iuliu Gabriel Cocuz, Maria Cătălina Popelea,

Raluca Niculescu

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(4), С. 2220 - 2220

Опубликована: Фев. 13, 2024

Basal cell carcinoma (BCC) and cutaneous squamous (cSCC) are the most frequently occurring non-melanocytic skin cancers. The objective of our study is to present pathophysiology BCC cSCC its direct relationship with histopathological diagnostics differential these types cancer, based on morphological characteristics, immunohistochemical profile, genetic alterations. qualitative was emphasizing characteristics immunohistochemistry profiles tissue samples from Clinical Pathology Department Mures County Hospital between 2020 2022. We analyzed appearances in comparison those Bowen disease, keratoacanthoma, hyperkeratotic papilloma, metatypical carcinoma, pilomatricoma, trichoblastoma, Merkel pleomorphic dermal sarcoma (PDS), melanoma. Our showed importance correct diagnosis, which has a impact appropriate treatment outcome for each patient. highlighted NMSCs precursor lesions HE profile that may make diagnosis difficult establish.

Язык: Английский

Процитировано

7

Multiple Keratoacanthoma-like Syndromes: Case Report and Literature Review DOI Creative Commons
Emmanouil Karampinis,

Christina Kostopoulou,

Olga Toli

и другие.

Medicina, Год журнала: 2024, Номер 60(3), С. 371 - 371

Опубликована: Фев. 22, 2024

Keratoacanthoma (KA) is a fast-growing skin tumor subtype that can be observed as solitary lesion or rarely multiple lesions in the context of rare genetic syndromes. Syndromes with keratoacanthoma-like have been documented self-healing squamous epithelioma (Ferguson–Smith syndrome), eruptive keratoacanthoma Grzybowski, familial Witten and Zak Muir–Torre syndrome, incontinentia pigmenti. The treatment approach those entities challenging due to numerous lesions, lesions’ undefined nature, co-existence other malignant tumors. Herein, we report case 40-year-old woman who developed treatment-resistant Ferguson–Smith-like keratoacanthomas co-existing large ulcerated invasive cell carcinoma microcystic adnexal on scalp. Multiple her extremities were successfully treated oral acitretin (0.5 mg/kg/day) combination topical Fluorouracil (5-FU) 5%, while excision plastic surgery restoration performed treat cancer Due interesting nature this literature review including reports series multiple-KA-like syndromes focusing diagnosis therapy approaches. We also conducted comparison patient reports, which included assessing clinical appearance evaluating success progress failure various approaches implemented.

Язык: Английский

Процитировано

4

The evolving landscape of laser-based skin cancer prevention DOI
Emily Wenande,

Molly Wanner,

Fernanda H. Sakamoto

и другие.

Lasers in Medical Science, Год журнала: 2025, Номер 40(1)

Опубликована: Фев. 6, 2025

Язык: Английский

Процитировано

0

Evaluation of dermoscopic findings in patients with cutaneous squamous cell carcinoma according to histopathological subtype and lesion morphology DOI Creative Commons
Mustafa Ürün, Yıldız Gürsel Ürün, Ömer Faruk Elmas

и другие.

Anais Brasileiros de Dermatologia, Год журнала: 2025, Номер unknown

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Rare Immuno-Induced Keratoacanthomas Showed on 18F-FDG PET/CT in a Metastatic Melanoma Patient DOI

Naia Oillarburu,

Cécile Pagès,

V. Sibaud

и другие.

Clinical Nuclear Medicine, Год журнала: 2025, Номер 50(5), С. e288 - e289

Опубликована: Апрель 3, 2025

Abstract A 76-year-old man managed for stage IV advanced melanoma was treated with nivolumab-ipilimumab, complicated by corticotropic insufficiency, hypothyroidism, and rash. At first evaluation, 18 F-FDG PET/CT clearly showed complete metabolic response allowing continued treatment nivolumab alone. 6 months, fully confirmed the persistence of but appearance cutaneous focal uptakes both lateral thighs a diffuse uptake on lower limbs. Clinically, he had severe verrucous lichenoid eruption eruptive keratoacanthomas, after resection. We report case rare immunotherapy-induced keratoacanthomas PET/CT.

Язык: Английский

Процитировано

0

Aberrant p16, p53 and Ki-67 immunohistochemistry staining patterns can distinguish solitary keratoacanthoma from cutaneous squamous cell carcinoma DOI
R. A. Carr,

Domenico Mesiano,

Cynthia Heffron

и другие.

Pathology, Год журнала: 2023, Номер 55(6), С. 772 - 784

Опубликована: Июль 20, 2023

Язык: Английский

Процитировано

10

Spontaneous resolution of eruptive papules following ablative laser resurfacing—Case report and review of laser‐associated eruptive keratoacanthomas DOI
Rahul Nanda, Joel L. Cohen

Journal of Cosmetic Dermatology, Год журнала: 2024, Номер 23(6), С. 1936 - 1939

Опубликована: Апрель 4, 2024

Abstract Background Keratoacanthomas (KAs) following laser treatment are a rare, but well‐described entity. Aim Herein, we describe case of eruptive keratoacanthoma (KA) resurfacing and aim to better characterize laser‐associated KAs. Methods A literature search was performed on PubMed reviewing KAs including various characteristics: epidemiology, history skin cancer, location, number, type laser, as well the management outcome. Results Fractional ablative most common triggering KAs, cases presented within first month treatment. The majority laser‐induced KA had prior malignant or premalignant neoplasm. Laser‐induced were treated using modalities similar arising in other contexts. Conclusion Clinicians need be knowledgeable prepared understand, manage complications treatments, rare they may be,

Язык: Английский

Процитировано

2

Distinguishing Keratoacanthoma from Well-Differentiated Cutaneous Squamous Cell Carcinoma Using Single-Cell Spatial Pathology DOI Creative Commons
Jesse Veenstra, David M. Ozog, Ian M. Loveless

и другие.

Journal of Investigative Dermatology, Год журнала: 2023, Номер 143(12), С. 2397 - 2407.e8

Опубликована: Июль 5, 2023

Язык: Английский

Процитировано

6

Multiple Eruptive Keratoacanthomas Secondary to Nivolumab Immunotherapy DOI
Eric Olsen, Steven A. Svoboda, Marjorie Montañez-Wiscovich

и другие.

Journal of Immunotherapy, Год журнала: 2023, Номер 47(3), С. 98 - 100

Опубликована: Ноя. 27, 2023

Immune checkpoint inhibitors are increasingly being utilized for the treatment of advanced neoplastic disease and have been associated with wide-ranging cutaneous adverse effects. Though exceedingly rare, eruptive keratoacanthomas use immune such as pembrolizumab nivolumab, whose molecular target is programmed cell death protein 1. Herein, we detail a case numerous arising in patient one month after initiation nivolumab recurrent metastatic oropharyngeal squamous carcinoma. Treatment multiple rounds intralesional corticosteroids several-month course oral acitretin resulted partial improvement. Subsequent 5-fluorouracil demonstrated near-complete resolution without discontinuation nivolumab. Although secondary to exceptionally physicians should be aware this effect their becomes more widespread.

Язык: Английский

Процитировано

4

A comparative analysis of keratoacanthomas and cutaneous squamous cell carcinoma treated with Mohs micrographic surgery DOI Open Access
David X. Gao, David M. Ozog, Jalal Maghfour

и другие.

Journal of the American Academy of Dermatology, Год журнала: 2024, Номер 90(4), С. 872 - 874

Опубликована: Янв. 8, 2024

Язык: Английский

Процитировано

1